CLIENTS PARTICIPANTS
Protein Shake and Semaglutide Study
This study is no longer recruiting additional participants.

 

INQUIS Clinical Research is currently recruiting participants for a research study on whether a high protein shake helps reduce side effects in people taking Ozempic/Wegovy injections.

We are looking for participants who are:

  • Taking weekly injections of Ozempic or Wegovy for weight loss for at least 4 weeks
  • Aged 18-75
  • BMI >27 kg/m2
  • No history of diabetes mellitus
  • Willing to consume a high protein shake daily for 7 days
  • Are able to complete questionnaires at home on an electronic device (eg. computer, laptop, smartphone)

This study involves:

  • Screening visit + 2 additional in-clinic morning visits
  • Consuming 1-2 high protein shakes daily for 7 days
  • Filling out GI Symptoms Questionnaires (in-clinic and at home electronically)

 

Qualified participants are eligible to receive compensation of up to $250.

To participate, please contact studies@inquis.com

Protein Shake and Semaglutide Study